Douglas A. Jabs

Q: What Schools Are Affiliated With Douglas A. Jabs

Douglas A. Jabs is affiliated with the following schools: Icahn School of Medicine at Mount Sinai, Johns Hopkins University

Douglas A. Jabs's AcademicInfluence.com Rankings

Douglas A. Jabs

Philosophy

#5525

World Rank

#8351

Historical Rank

Logic

#2790

World Rank

#3832

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Douglas A. Jabs's Degrees

Doctorate Medicine University of Pennsylvania

Why Is Douglas A. Jabs Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Douglas A. Jabs's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. (2005) (3335)
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. (2000) (892)
Guidelines for preventing opportunistic infections among HIV-infected persons - 2002 (2002) (474)
Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. (2014) (404)
Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. (2014) (404)
Cytomegalovirus retinitis and acquired immunodeficiency syndrome. (1989) (371)
Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. (2001) (369)
Ocular manifestations of HIV infection. (1995) (368)
Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis (1991) (351)
Episcleritis and scleritis: clinical features and treatment results. (2000) (327)
Ocular involvement in chronic sarcoidosis. (1986) (322)
Thalidomide for the treatment of chronic graft-versus-host disease. (1992) (291)
Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. (2011) (275)
Ocular manifestations of acquired immune deficiency syndrome. (1989) (267)
Methotrexate for ocular inflammatory diseases. (2009) (267)
Evaluation of patients with scleritis for systemic disease. (2004) (232)
Cyclosporine for ocular inflammatory diseases. (2010) (226)
Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. (1989) (212)
Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. (2007) (209)
Mycophenolate mofetil for ocular inflammation. (2010) (208)
Azathioprine for ocular inflammatory diseases. (2009) (205)
Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. (2008) (197)
Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy. (1991) (194)
Mucous membrane pemphigoid and pseudopemphigoid. (2004) (190)
The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. (2010) (182)
Severe retinal vaso-occlusive disease in systemic lupus erythematous. (1986) (177)
The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. (1989) (172)
Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. (2007) (166)
The Eye in Bone Marrow Transplantation: VI. Retinal Complications (1994) (164)
Summary of the II International Symposium on Cytomegalovirus. (1998) (163)
The eye in bone marrow transplantation. I. Clinical study. (1983) (163)
Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. (2010) (163)
Cytomegalovirus Retinitis and Viral Resistance: Ganciclovir Resistance (1998) (162)
Treatment of cytomegalovirus retinitis with ganciclovir. (1987) (162)
Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study (2009) (162)
Mycophenolate mofetil therapy for inflammatory eye disease. (2005) (161)
Incidence of cystoid macular edema after cataract surgery in patients with and without uveitis using optical coherence tomography. (2009) (155)
Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. (2000) (153)
Microvascular aspects of acquired immune deficiency syndrome retinopathy. (1984) (147)
Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. (2013) (147)
Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. (2007) (145)
Cyclophosphamide for ocular inflammatory diseases. (2009) (144)
Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. (2002) (144)
AIDS and ophthalmology: a period of transition. (1997) (143)
Optic neuropathy in systemic lupus erythematosus. (1986) (142)
Pars planitis: clinical features and class II HLA associations. (1999) (142)
Birdshot retinochoroidopathy: ocular complications and visual impairment. (2005) (140)
Improving the reporting of clinical case series. (2005) (140)
Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy. (1998) (138)
Choroidopathy in systemic lupus erythematosus. (1988) (136)
Clinical features and associated systemic diseases of HLA-B27 uveitis. (1996) (132)
Retinal detachments in patients with cytomegalovirus retinitis. (1991) (130)
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. (2008) (126)
Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. (2001) (123)
Syphilitic uveitis in human immunodeficiency virus-infected patients. (1997) (122)
Approach to the diagnosis of the uveitides. (2013) (122)
Periocular corticosteroid injections in uveitis: effects and complications. (2014) (121)
Early Outpatient Treatment for Covid-19 with Convalescent Plasma (2022) (120)
Incidence of Foscarnet Resistance and Cidofovir Resistance in Patients Treated for Cytomegalovirus Retinitis (1998) (116)
The eye in bone marrow transplantation. II. Histopathology. (1983) (115)
Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. (2006) (115)
Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture. (2011) (113)
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. (2008) (112)
Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). (1989) (111)
Punctate inner choroidopathy: a survey analysis of 77 persons. (2007) (110)
Current practices in the management of ocular toxoplasmosis. (1991) (109)
Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma. (1990) (106)
Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial. (2019) (106)
A METHOD OF REPORTING MACULAR EDEMA AFTER CATARACT SURGERY USING OPTICAL COHERENCE TOMOGRAPHY (2008) (104)
Immunosuppression for the Uveitides. (2017) (103)
Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. (2012) (103)
Methods for Identifying Long-Term Adverse Effects of Treatment in Patients with Eye Diseases: The Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study (2008) (102)
MULTIFOCAL CHOROIDITIS WITH PANUVEITIS AND PUNCTATE INNER CHOROIDOPATHY: Comparison of Clinical Characteristics at Presentation (2007) (98)
Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis and Cytomegalovirus Infection. (1996) (98)
Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment. (2007) (98)
Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression. (2004) (92)
Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy. (2003) (90)
Vogt-Koyanagi-Harada disease: clinical outcomes. (2005) (89)
Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome. (2003) (88)
Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome. (2001) (86)
Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy. (2005) (86)
Multifocal choroiditis with panuveitis incidence of ocular complications and of loss of visual acuity. (2006) (85)
Successful treatment of serpiginous choroiditis with alkylating agents. (2002) (84)
Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. (2003) (84)
Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis (2017) (84)
Studies of ocular complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design, and methods. AIDS Clinical Trials Group (ACTG). (1992) (81)
Risk of choroidal neovascularization among the uveitides. (2013) (80)
Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment. (2004) (77)
Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy. (2008) (77)
Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection. (2004) (76)
Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography. (2011) (76)
Loss of visual field among patients with birdshot chorioretinopathy. (2008) (74)
Fomivirsen for the treatment of cytomegalovirus retinitis. (2002) (73)
Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice. (1992) (73)
Ocular toxoplasmosis misdiagnosed as cytomegalovirus retinopathy in immunocompromised patients. (1994) (72)
Periocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitis. (2011) (69)
Optic disc edema after bone marrow transplantation. Possible role of cyclosporine toxicity. (1991) (69)
Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. (2006) (68)
Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. (1995) (68)
Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. (2015) (67)
Smoking as a risk factor for cystoid macular edema complicating intermediate uveitis. (2008) (66)
HLA typing in uveitis: use and misuse. (2010) (66)
Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eye. (2009) (65)
Vision function in HIV-infected individuals without retinitis: report of the Studies of Ocular Complications of AIDS Research Group. (2008) (65)
PRESUMED VARICELLA ZOSTER RETINITIS IN IMMUNOCOMPROMISED PATIENTS (1987) (65)
Reactive lymphocytes in lacrimal gland and vasculitic renal lesions of autoimmune MRL/lpr mice express L3T4 (1987) (64)
Multifocal choroiditis in patients with familial juvenile systemic granulomatosis. (2002) (64)
Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes. (2010) (64)
Response of Pediatric Uveitis to Tumor Necrosis Factor-α Inhibitors (2013) (63)
Hypopyon in patients with uveitis. (2010) (61)
Lichen planus and cicatrizing conjunctivitis: characterization of five cases. (2003) (61)
The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial. (2001) (61)
Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. (2006) (60)
1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus (1999) (59)
Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results. (2015) (59)
Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy: Results from a United States Cohort. (2015) (56)
Murine models of Sjögren's syndrome. Immunohistologic analysis of different strains. (1988) (56)
Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis. (2003) (56)
Measuring visual function and quality of life in patients with cytomegalovirus retinitis. Development of a questionnaire. Studies of Ocular Complication of AIDS Research Group. (1996) (55)
Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. (1997) (54)
Ocular disease in patients with ANCA-positive vasculitis (2009) (54)
The Impact of Macular Edema on Visual Function in Intermediate, Posterior, and Panuveitis (2012) (53)
Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy. (2013) (53)
Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group. (1996) (53)
Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. (2000) (53)
The eye in bone marrow transplantation. VI. Retinal complications. (1994) (52)
Ocular inflammation in autoimmune MRL/Mp mice. (1985) (52)
Vascular endothelial growth factor inhibition in uveitis: a systematic review (2010) (52)
Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. (2003) (51)
The Risk of Intraocular Pressure Elevation in Pediatric Noninfectious Uveitis. (2015) (51)
Bone marrow transplantation and cataract development. (1993) (50)
Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group. (1998) (49)
Mortality in Hepatitis C Virus–Infected Patients With a Diagnosis of AIDS in the Era of Combination Antiretroviral Therapy (2012) (49)
Low Rate of CMV End-Organ Disease in HIV-Infected Patients Despite Low CD4+ Cell Counts and CMV Viremia: Results of ACTG Protocol A5030 (2009) (49)
Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema. (2014) (48)
Interobserver Agreement Among Uveitis Experts on Uveitic Diagnoses: The Standardization of Uveitis Nomenclature Experience. (2018) (48)
Cytomegalovirus retinitis and low CD4+ T-lymphocyte counts. (1995) (47)
Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis. (2007) (46)
Development of classification criteria for the uveitides. (2021) (46)
Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir. (1995) (45)
Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions. (1991) (45)
IMMUNOSUPPRESSION FOR POSTERIOR UVEITIS (2005) (45)
Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice. (2000) (45)
Comparison of cytomegalovirus (CMV) UL97 gene sequences in the blood and vitreous of patients with acquired immunodeficiency syndrome and CMV retinitis. (2002) (45)
Safety of Intravitreal Ketorolac and Diclofenac: An Electroretinographic and Histopathologic Study (2008) (44)
Cytomegalovirus (CMV) blood DNA load, CMV retinitis progression, and occurrence of resistant CMV in patients with CMV retinitis. (2005) (44)
Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment Trial and Follow-up Study. (2015) (44)
Adverse effects of smoking on patients with ocular inflammation (2010) (43)
Standardization of Nomenclature for Ocular Tuberculosis – Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop (2019) (43)
Hypotony in Patients with Uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial (2011) (43)
Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: The foscarnet-ganciclovir cytomegalovirus retinitis trial (1997) (43)
Adalimumab for Ocular Inflammation (2012) (42)
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 1: Guidelines for Initiating Antitubercular Therapy in Tubercular Choroiditis. (2020) (41)
Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS: The cytomegalovirus retreatment trial (1996) (41)
RETINAL VASCULAR OCCLUSION IN PATIENTS INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS (2005) (41)
Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: The Cytomegalovirus and Viral Resistance Study Group Report Number 8. (2001) (40)
Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis. (2014) (40)
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma (2021) (40)
BW B759U for cytomegalovirus retinitis: intraocular drug penetration. (1986) (40)
Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype. (2006) (39)
Risk of hypotony in noninfectious uveitis. (2012) (39)
Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis: correlation of genotypic methods with viral phenotype and clinical outcome. (2006) (39)
Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice. (2000) (38)
Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial. (2015) (37)
Correlates of Hypertension in Patients with AIDS in the Era of Highly Active Antiretroviral Therapy (2013) (36)
Factors affecting attrition in a longitudinal study of patients with AIDS (2006) (36)
Improved visual results after surgical repair of cytomegalovirus-related retinal detachments. (1994) (35)
HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial (2002) (34)
Risk of Retinal Neovascularization in Cases of Uveitis. (2016) (33)
Epiretinal membranes in uveitic macular edema: effect on vision and response to therapy. (2014) (33)
Ocular manifestations of vasculitis. (2001) (33)
Effect of host genetics on the development of cytomegalovirus retinitis in patients with AIDS. (2010) (32)
Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis. (2011) (32)
Mortality associated with resistant cytomegalovirus among patients with cytomegalovirus retinitis and AIDS. (2010) (31)
High-dose Intravenous Corticosteroids for Ocular Inflammatory Diseases (2012) (31)
Treatment of cytomegalovirus retinitis--1992. (1992) (31)
Risk of Ocular Hypertension in Adults with Noninfectious Uveitis. (2017) (30)
Regression of cytomegalovirus retinitis with zidovudine. A clinicopathologic correlation. (1989) (30)
Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS. (2007) (30)
Epidemiology of Uveitis (2008) (30)
Success with single-agent immunosuppression for multifocal choroidopathies. (2014) (30)
Cataract Surgery Outcomes in Uveitis: The Multicenter Uveitis Steroid Treatment Trial. (2016) (30)
Remission of Intermediate Uveitis: Incidence and Predictive Factors. (2016) (29)
Comparison of Cytomegalovirus Loads in Plasma and Leukocytes of Patients with Cytomegalovirus Retinitis (1999) (28)
Risk of relapse in primary acute anterior uveitis. (2011) (28)
The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy. (2003) (27)
Association between abnormal contrast sensitivity and mortality among people with acquired immunodeficiency syndrome. (2010) (26)
Multicohort genomewide association study reveals a new signal of protection against HIV-1 acquisition. (2012) (26)
Subretinal fluid in uveitic macular edema: effect on vision and response to therapy. (2013) (26)
Effects of early and late treatment with anti-CD4 monoclonal antibody on autoimmune disease in MRL/MP-lpr/lpr mice. (1994) (26)
Incidence and long-term outcomes of the human immunodefıciency virus neuroretinal disorder in patients with AIDS. (2015) (25)
Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Studies of Ocular Complications of AIDS Research Group. (2000) (25)
Murine models of Sjögren's syndrome. (1994) (25)
AIDS and ophthalmology, 2008. (2008) (25)
T cell subsets and cytomegalovirus retinitis in human immunodeficiency virus-infected patients. (1997) (25)
Restoration of Retinal Architecture following Systemic Immunosuppression in Birdshot Chorioretinopathy (2010) (25)
Mitochondrial Haplogroups Are Associated With Risk of Neuroretinal Disorder in HIV-Positive Patients (2010) (25)
COMPLICATIONS OF GANCICLOVIR IMPLANT SURGERY IN PATIENTS WITH CYTOMEGALOVIRUS RETINITIS: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial (2004) (25)
The Ocular Manifestations of Graft-Versus-Host Disease (1997) (24)
Cytomegalovirus retinitis and viral resistance: 3. Culture results. CMV Retinitis and Viral Resistance Study Group. (1998) (24)
Visual acuity outcome of non-infectious intermediate, posterior, and panuveitis in the Multicenter Uveitis Steroid Treatment (MUST) Trial (2014) (24)
Disappearance of classic birdshot spots after immunosuppression with tacrolimus and mycophenolate mofetil (2008) (24)
Incidence of Intermediate-stage Age-related Macular Degeneration in Patients With Acquired Immunodeficiency Syndrome. (2015) (23)
Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice. (1996) (23)
Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis. (2005) (23)
Cytokines in autoimmune lacrimal gland disease in MRL/MpJ mice. (2001) (23)
Uveitis for the non-ophthalmologist (2021) (23)
Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases. (2012) (22)
AIDS and ophthalmology in 2004. (2004) (22)
Classification criteria for Vogt-Koyanagi-Harada Disease. (2021) (21)
Classification criteria for sarcoidosis-associated uveitis. (2021) (20)
Cytomegalovirus retinitis in HIV-infected patients with elevated CD4+ counts. (1995) (20)
Classification criteria for Fuchs uveitis syndrome. (2021) (19)
The standardization of uveitis nomenclature project: the future is here. (2013) (19)
Classification criteria for tubercular uveitis. (2021) (19)
Comparison between Methotrexate and Mycophenolate Mofetil monotherapy for the control of Non- Infectious Ocular Inflammatory Diseases. (2019) (19)
Cytomegalovirus retinitis in AIDS: natural history, diagnosis, and treatment. (1995) (19)
Visual field loss in patients with cytomegalovirus retinitis. (2011) (19)
Effect of Host Genetics on Incidence of HIV Neuroretinal Disorder in Patients With AIDS (2010) (19)
Reliability, validity, and responsiveness of general and disease-specific quality of life measures in a clinical trial for cytomegalovirus retinitis. (2001) (19)
Prevalence of intermediate-stage age-related macular degeneration in patients with acquired immunodeficiency syndrome. (2015) (18)
Ischaemic optic neuropathy with painful ophthalmoplegia in diabetes mellitus. (1981) (18)
Classification criteria for Behçet Disease Uveitis. (2021) (18)
Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. (2016) (18)
Longitudinal Vision-Related Quality of Life for Patients with Noninfectious Uveitis Treated with Fluocinolone Acetonide Implant or Systemic Corticosteroid Therapy. (2017) (18)
Treatment of ocular inflammation (2004) (18)
Classification criteria for birdshot chorioretinitis. (2021) (18)
Discoid lupus erythematosus and cicatrizing conjunctivitis: clinicopathologic study of two cases (2002) (17)
The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice. (2001) (17)
Classification criteria for cytomegalovirus anterior uveitis. (2021) (17)
Autoimmune ocular disease in MRL/Mp-lpr/lpr mice is suppressed by anti-CD4 antibody. (1991) (17)
Cytomegalovirus Retinitis in Patients With Acquired Immunodeficiency Syndrome After Initiating Antiretroviral Therapy. (2017) (17)
Viral resistance and CMV retinitis: design and methods of a prospective study. CRVR Research Groups. Cytomegalovirus Retinitis Viral Resistance Research Group. (1997) (17)
Risk of cataract among subjects with acquired immune deficiency syndrome free of ocular opportunistic infections. (2014) (16)
Risk of Cataract Development among Children with Juvenile Idiopathic Arthritis-Related Uveitis Treated with Topical Corticosteroids. (2020) (16)
Acquired Immunodeficiency Syndrome and the Eye—1996 (1996) (16)
Incidence and management of cataract after retinal detachment repair with silicone oil in immune compromised patients with cytomegalovirus retinitis. (2003) (16)
Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice. (2004) (16)
Factors predictive of remission of new-onset anterior uveitis. (2014) (16)
Scleral nodule associated with sarcoidosis. (2003) (16)
Classification criteria for acute retinal necrosis syndrome. (2021) (15)
Treatment of Cytomegalovirus Retinitis in Patients with AIDS (1996) (15)
Classification criteria for multifocal choroiditis with panuveitis. (2021) (15)
Secular trends in opportunistic infections, cancers and mortality in patients with AIDS during the era of modern combination antiretroviral therapy (2018) (15)
Classification criteria for multiple evanescent white dot syndrome. (2021) (15)
Risk of cataract in persons with cytomegalovirus retinitis and the acquired immune deficiency syndrome. (2012) (15)
Relationship Between Opacity of Cytomegalovirus Retinitis Lesion Borders and Severity of Immunodeficiency Among People With AIDS (2019) (14)
Association of host genetic risk factors with the course of cytomegalovirus retinitis in patients infected with human immunodeficiency virus. (2011) (14)
Remission Of Non-Infectious Anterior Scleritis: Incidence And Predictive Factors. (2019) (14)
Recurrent Nodular Scleritis Preceding an Adult TINU Syndrome (2006) (14)
Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration. (2007) (14)
Autoimmune Th2-mediated dacryoadenitis in MRL/MpJ mice becomes Th1-mediated in IL-4 deficient MRL/MpJ mice. (2007) (14)
Transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection: a double-blinded, phase 2 randomized, controlled trial (2022) (14)
Catheter complications in AIDS patients treated for cytomegalovirus retinitis (1998) (14)
The eye and rheumatic disease. (1998) (13)
Optical Coherence Tomography Imaging of Presumed Sarcoid Retinal and Optic Nerve Nodules (2014) (13)
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. (2001) (13)
Ophthalmic complications of HIV infection. (1996) (13)
Discussion by Douglas A. Jabs, MD, MBA (2002) (13)
Classification criteria for cytomegalovirus retinitis. (2021) (13)
Classification criteria for Sympathetic Ophthalmia. (2021) (13)
Classification criteria for punctate inner choroiditis. (2021) (13)
Ocular inflammation in MRL/Mp-lpr/lpr mice. (1991) (12)
Leukemic iris infiltration. (1988) (12)
Data and safety monitoring board deliberations resulting in the early termination of the Monoclonal Antibody Cytomegalovirus Retinitis Trial. (2003) (12)
Classification criteria for spondyloarthritis/HLA-B27-associated anterior uveitis. (2021) (12)
Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome. (2013) (12)
Optic neuropathy complicating multifocal choroiditis and panuveitis. (2007) (11)
Classification criteria for herpes simplex virus anterior uveitis. (2021) (11)
Challenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial – lessons for comparative effectiveness trials (2011) (11)
Exudative Retinal Detachment in Ocular Inflammatory Diseases: Risk and Predictive Factors. (2020) (11)
Relationship between Human Immunodeficiency Virus Neuroretinal Disorder and Vision-Specific Quality of Life among People with AIDS. (2015) (11)
Classification criteria for varicella zoster virus anterior uveitis. (2021) (11)
Treatment Options for Juvenile Idiopathic Arthritis (JIA) Associated Uveitis (2016) (11)
Optic disc sarcoid granuloma. (2000) (11)
Seven-year outcomes of uveitic macular edema: the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study results. (2020) (10)
Classification criteria for tubulointerstitial nephritis with uveitis syndrome. (2021) (10)
Peripheral Cryoablation for Treatment of Active Pars Planitis: Long-Term Outcomes of a Retrospective Study. (2016) (10)
The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting Proceedings (2020) (10)
Assessing the Precision of ICD-10 Codes for Uveitis in 2 Electronic Health Record Systems (2018) (10)
Role of electron microscopy in the diagnosis of ocular mucous membrane pemphigoid. (2006) (10)
Improving the Diagnostic Criteria for Vogt-Koyanagi-Harada Disease. (2018) (9)
Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients. (2001) (9)
Ocular microvasculopathy after bone marrow transplantation. (1992) (9)
Clinician versus reading center assessment of cytomegalovirus retinitis lesion size. (2005) (9)
Paradoxic effect of anti-CD4 therapy on lacrimal gland disease in MRL/Mp-lpr/lpr mice. (1996) (9)
Cytomegalovirus retinitis in the era of highly active antiretroviral therapy. (2007) (9)
Visual Acuity Outcome over Time in Non-Infectious Uveitis (2019) (8)
Association of Age-related Macular Degeneration With Mortality in Patients With Acquired Immunodeficiency Syndrome; Role of Systemic Inflammation. (2019) (8)
Classification criteria for pars planitis. (2021) (8)
Cytomegalovirus retinitis and the evolving AIDS epidemic. (1998) (8)
Classification criteria for juvenile idiopathic arthritis-associated chronic anterior uveitis. (2021) (7)
Factors Predictive of Remission of Chronic Anterior Uveitis. (2019) (7)
Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS. (2008) (7)
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection (2021) (7)
Risk Factors for Loss of Visual Acuity among Patients with Uveitis Associated With Juvenile Idiopathic Arthritis: The SITE Study (2012) (7)
Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir. (1995) (7)
Rheumatic disease and scleritis. (2007) (7)
Classification criteria for acute posterior multifocal placoid pigment epitheliopathy. (2021) (7)
Role of T cells in the pathogenesis of autoimmune lacrimal gland disease in MRL/Mp-lpr/lpr mice. (1997) (6)
Comparability of two fundus photograph reading centers in grading cytomegalovirus retinitis progression. (2004) (6)
Association of Systemic Inflammation With Retinal Vascular Caliber in Patients With AIDS (2019) (6)
Classification criteria for serpiginous choroiditis. (2021) (6)
Antimetabolite Therapy for Uveitis: Methotrexate or Mycophenolate? (2019) (6)
Use of filgrastim as adjuvant therapy in patients with AIDS-related cytomegalovirus retinitis (2002) (6)
Classification criteria intermediate uveitis, non-pars planitis type. (2021) (6)
Education in the ophthalmic discipline of uveitis. (2008) (6)
Ocular toxoplasmosis. (1990) (5)
Risk of Overall and Cancer Mortality After Immunosuppression of Patients with Non-infectious Ocular Inflammatory Diseases. (2019) (5)
RETINAL FINDINGS IN PRESUMED INFECTIOUS POSTERIOR UVEITIS AND CORRELATION WITH POLYMERASE CHAIN REACTION RESULTS. (2020) (5)
Prevalence of the Uveitides in the United States. (2016) (5)
ORIGINAL ARTICLE Posterior Intracorneal Opacities in Patients with HIV Infection (2005) (5)
Risk of Cataract in Intermediate Uveitis. (2021) (4)
CHARACTERIZATION OF THE CLASS I HLA 9.2‐kb PVU II RESTRICTION FRAGMENT LENGTH POLYMORPHISM: Linkage to HLA‐A and Lack of Disease Association (1989) (4)
Patient notification and follow-up after suspension of treatment protocols. experience from four clinical trials of treatments for AIDS-related CMV retinitis. (2001) (4)
Association of Retinal Vascular Caliber and Age-Related Macular Degeneration in Patients With the Acquired Immunodeficiency Syndrome (2018) (4)
Acquired immunodeficiency syndrome and the eye--1996. (1996) (4)
Oscillatory potentials in patients with birdshot chorioretinopathy (2020) (4)
Benefits of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Intraocular Implant for Intermediate, Posterior and Panuveitis: 54 month results of The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study (2015) (4)
Multimodal Imaging of a Tuberculous Granuloma. (2015) (4)
Pharmacoeconomic Analysis of 3 Treatment Strategies for Cytomegalovirus Retinitis in Patients with AIDS (1998) (4)
34 – The eye in rheumatic disease (2014) (4)
Design of clinical trials for drug combinations: cytomegalovirus retinitis--foscarnet and ganciclovir. The CMV retinitis retreatment trial. (1996) (4)
Incidence and Risk Factors for Ocular Hypertension in Adults with Non-infectious Uveitis (2014) (3)
Influence of filgrastim (granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitis. (2002) (3)
GWATCH: a web platform for automated gene association discovery analysis (2014) (3)
Epidemiologic Methods for Detecting Rare, Long-Term Adverse Events Associated With Eye Diseases: The Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study (2007) (3)
Incremental Cost Effectiveness of Prophylaxis for Cytomegalovirus Disease in Patients with AIDS (2012) (3)
Regional corticosteroids for scleritis. (2012) (3)
Cidofovir for Cytomegalovirus Retinitis: Reply (1997) (3)
Evaluation of hepatitis C virus as a risk factor for HIV-associated neuroretinal disorder. (2013) (2)
Risk of Cataract Development Among Children With Juvenile Idiopathic Arthritis (JIA)-Associated Chronic Anterior Uveitis Treated With Topical Corticosteroids (2009) (2)
Visual Acuity Loss Among Patients With AIDS and CMV Retinitis in the Era of Highly Active Antiretroviral Therapy (HAART) (2006) (2)
Pathogenesis of autoimmune lacrimal gland disease in MRL/MPJ mice. (2002) (2)
Incidence and outcome of uveitic glaucoma in eyes with intermediate, posterior or panuveitis followed up to 10 years after randomization to fluocinolone acetonide implant or systemic therapy. (2020) (2)
Intravenous Pulsed Corticosteroids for Ocular Inflammatory Diseases (2010) (2)
Chapter 89 – Ocular Toxoplasmosis (2006) (2)
Methotrexate vs. Mycophenolate Mofetil for Ocular Inflammatory Diseases (2012) (2)
Chapter 75 – Rheumatic Diseases (2006) (2)
Corneal Endothelial Transplantation in Uveitis: Incidence and Risk Factors. (2021) (2)
Risk of Elevated Intraocular Pressure (IOP) in Pediatric Non-infectious Uveitis (2014) (2)
Risk Factors For Retinal Neovascularization In Patients With Uveitis (2011) (1)
Simultaneous, multiple cranial neuropathies in patients with diabetes mellitus. (1996) (1)
Takayansu's Arteritis Associated with Anterior Uveitis and Cutaneous Extravascular Necrotizing Granuloma. (1998) (1)
Current Considerations for Clinical Management and Care of People with HIV: Findings from the 11th Annual International HIV & Aging Workshop. (2021) (1)
Ophthalmologic Aspects of HIV Infection (2004) (1)
Chapter 78 – Sarcoidosis (2013) (1)
Birdshot Chorioretinitis: Treatment & Remission Outcomes (2019) (1)
APOL1 variant alleles associate with reduced risk for opportunistic infections in HIV infection (2021) (1)
The impact of macular edema on visual function in uveitis (2011) (1)
Reply to comment on: "Classification Criteria for Behcet Disease Uveitis". (2021) (1)
Pathogenesis of autoimmune lacrimal gland disease in MRL/MPJ mice (2002) (1)
The standardisation of uveitis nomenclature (SUN) project (2022) (1)
Uveitis is a subspeciality. (2012) (1)
Contemporaneous Risk Factors for Visual Acuity in Non-Infectious Uveitis. (2021) (1)
Stratification Clarification for Methods for Randomized Clinical Trials-Reply. (2020) (1)
Association of elevated plasma inflammatory biomarker levels with age-related macular degeneration but not cataract in persons with AIDS (2021) (1)
The conundrum of clinical trials for the uveitides: appropriate outcome measures for one treatment used in several diseases. (2022) (1)
Ocular manifestations of AIDS (1990) (1)
Treatment of Optic Neuropathy With Megadose Corticosteroids-Reply (1986) (1)
Analysis of Cystoid Macular Edema After Cataract Surgery in Patients With and Without Uveitis Using Optical Coherence Tomography (2007) (1)
Diagnosis and Treatment of Neurologic Disorders in AIDS and Other Sexually Transmitted Diseases (1990) (1)
CIDOFOVIR FOR CYTOMEGALOVIRUS RETINITIS. AUTHORS' REPLY (1997) (1)
Risk Of Clinically Manifest Hyperglycemia Among Patients Receiving Systemic Corticosteroids For Inflammatory Eye Disease (2011) (0)
Unperceived Visual Field Defects-Reply (1997) (0)
Dissociations of fluocinolone acetonide implants in the MUST study (2015) (0)
Treatment of CMV retinopathy in patients with AIDS. (1996) (0)
A Standardized Method of Reporting Macular Edema After Cataract Surgery Using Optical Coherence Tomography (2007) (0)
Posterior Subtenons Corticosteroid Injections for Cystoid Macular Edema Complicating Noninfectious Uveitis (2008) (0)
Limitations of Cytomegalovirus Testing (1999) (0)
Incidence and Risk factors for Hypotony in Uveitis (2011) (0)
Risk factors for reduced visual acuity in non-infectious intermediate, posterior, and panuveitis (2014) (0)
Antibody Correlates of Protection for COVID-19 Convalescent Plasma Associated with Reduced Outpatient Hospitalizations (2023) (0)
Immunologic and Virologic Laboratory Parameters Associated With Active AIDS-Related Cytomegalovirus Retinitis in the Era of Highly Active Antiretroviral Therapy (2009) (0)
The Impact of Cytomegalovirus Retinitis on the Quality of Life of Patients with the Acquired Immune Deficiency Syndrome (2003) (0)
Improved Visual Results After Surgical Repair of Cytomegalovirus-Related Retinal Detachments (1995) (0)
Ocular Disease in Patients With Wegener’s Granulomatosis (2008) (0)
Retinal detachment risk in cytomegalovirus retinitis related to aids (2001) (0)
Lessons on immune evasion in the retina by viruses secondary to AIDS (2016) (0)
Analysis of Survey of Patients With Punctate Inner Choroidopathy (2006) (0)
Cytomegalovirus Retinitis Incidence in the Highly Active Antiretroviral Therapy (HAART) Era (2011) (0)
Chemokine Expression in Autoimmune Lacrimal Gland Disease in MRL/MpJ Mice (2003) (0)
ACQUIRED IMMUNODEFICIENCY SYNDROME AND THE EYE. AUTHOR'S REPLY (1997) (0)
Incremental Cost-Effectiveness of Fluocinolone Acetonide Implant vs Systemic Therapy for Non-infectious Intermediate, Posterior, and Pan-Uveitis (2014) (0)
Grading CMV Retinitis Progression Compared Between Two Reading Centers (2003) (0)
Incidence of Age-Related Macular Degeneration in Patients with the Acquired Immune Deficiency Syndrome (2017) (0)
Uveitis and Clinical Trials (2016) (0)
Association of age-related macular degeneration with mortality in patients with AIDS; role of systemic inflammation (2019) (0)
Risks and Quality of Life associated with Fluocinolone Acetonide Intraocular Implant Versus Systemic Anti-inflammatory Therapy for Intermediate, Posterior or Panuveitis: 4.5 year results of The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study (2015) (0)
Clinical Characteristics of Mucous Membrane Pemphigoid and Pseudopemphigoid (2003) (0)
Chapter 103 – Sarcoidosis (2006) (0)
Future Ophthalmology: The Cutting Edge (2013) (0)
Azathioprine for Non-infectious Ocular Inflammation (2009) (0)
Time : 11 : 00 AM – 11 : 15 AM Incidence of Age-Related Macular Degeneration in Patients with the Acquired Immune Deficiency Syndrome (2017) (0)
Dissociations of the fluocinolone acetonide implant: experience from long-term follow-up during the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study (2018) (0)
Author reply: To PMID 24359625. (2014) (0)
Treatment outcomes in birdshot chorioretinitis: corticosteroid sparing, corticosteroid discontinuation, remission, and relapse. (2022) (0)
Scleritis in Lyme Disease. (2022) (0)
Discontinuing anticytomegalovirus therapy in patients with cytomegalovirus retinitis and AIDS (2001) (0)
Clinical Outcomes of Patients With Juvenile Idiopathic Arthritis (JIA) Associated Uveitis (2007) (0)
Simultanous, Multiple Cranial Neurophathies in Patients with Diabetes Mellitus (1996) (0)
Long-term visual acuity outcomes following cataract surgery in eyes with ocular inflammatory disease (2023) (0)
Reply to Comment on SUN Classification Criteria for Vogt-Koyanagi-Harada Disease. (2022) (0)
The architecture of the corneal stroma (0)
Visual Field Loss in Birdshot Chorioretinitis (2007) (0)
Evolution of rhe Locrimol G/ond Inflommorory Lesions (1991) (0)
Association of Age-related Macular Degeneration with Retinal Vascular Caliber in Patients with the Acquired Immunodeficiency Syndrome (2018) (0)
Risk of Immune Recovery Uveitis in Patients With Cytomegalovirus Retinitis and the Acquired Immune Deficiency Syndrome (2005) (0)
CMV Retinitis is a Risk Factor for Mortality inPatients with AIDS in the Era of HAART (2004) (0)
Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir. (1997) (0)
Risk of Loss of Visual Acuity for Patients With AIDS (2006) (0)
Risk Of Cataract In Persons With Acquired Immune Deficiency Syndrome And Cytomegalovirus Retinitis (2012) (0)
Pujari et al Cyclophosphamide for Ocular Inflammation (0)
Remission Of Intermediate Uveitis: Rate And Predictive Factors (2012) (0)
Comparison of PCR Amplication and UL97 Gene Sequencing of Blood Specimens v UL97 Gene Sequencing of Culture Isolates for Ganciclovir–Resistant Cytomegalovirus (CMV) in Patients With CMV Retinitis (2006) (0)
The Prevalence, Incidence and Risk Factors for Exudative Retinal Detachment in Uveitis (2013) (0)
Effects of early and late treatment with anti-CD4 monoclonal antibody on ocular lesions in MRL/Mp-lpr/lpr mice (1994) (0)
Clinical Outcomes of Patients With Behcet’s Disease Associated Ocular Inflammation (2008) (0)
Visual Acuity in Patients with Non-Infectious Uveitis: Outcome Over Time and Risk Factors (2012) (0)
Mycophenolate Mofetil in Non-Infectious Ocular Inflammatory Diseases (2009) (0)
Retina Association of Retinal Vascular Caliber and Age-Related Macular Degeneration in Patients With the Acquired Immunodeficiency Syndrome (2018) (0)
Agreement among Uveitis Experts on Diagnosis: The SUN Classification Criteria Project Experience (2016) (0)
Clinician vs. Reading Center Assessment of Cytomegalovirus Retinitis Lesion Area (2004) (0)
Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Intraocular Implant for Intermediate, Posterior or Panuveitis: 54 month results of The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study (2015) (0)
Relationships between HIV-related Neuroretinal Disorder and Measures of Vision-Specific Quality of Life among People with AIDS (2015) (0)
Clinical Outcomes of Ocular Inflammatory Disease Patients Treated With Cyclosporine-A as a Single Immunomodulatory Agent (2009) (0)
Association of Host Genetic Risk Factors with the Course of Cytomegalovirus Retinitis in Patients Infected with HIV (2011) (0)
Identifying a Clinically Meaningful Threshold for Change in Macular Edema in Patients with Uveitis (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Douglas A. Jabs?

Douglas A. Jabs is affiliated with the following schools: